|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.10 USD | -5.41% |
|
-19.99% | -31.06% |
| 07-13 | Tarsus Pharmaceuticals, Inc. Announces Management Changes, Effective July 13, 2026 | CI |
| 07-13 | Tarsus Pharmaceuticals Appoints Neera Clase as Interim Chief Commercial Officer | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 2.55B | - | - | - | ||
| 67.46B | |||||
| 51.13B | |||||
| 43.4B | |||||
| 40.32B | - | ||||
| 30.86B |
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
